In a press release this Tuesday, Solvay and INEOS announced they had the go-ahead from the European Commission with regards to INOVYN, their joint venture in chlorovinyls. “The Commission has indeed endorsed the transfer of a number of industrial assets from INEOS to the International Chemical Investors Group (ICIG), a prerequisite for the final approval,” the two companies added.
INOVYN will have its headquarters in London and will display a pro forma turnover of over 3 billion euros with its 18 plants located in Belgium, France, Germany, Italy, Norway, Sweden and the United Kingdom. The transaction is expected to be completed by July 1st.
Lars Andersen (Source: Belga)